+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Facial Injectable Market Size, Share & Trends Analysis Report by Product (Collagen & PMMA Microspheres, Hyaluronic Acid), Application (Facial Line Correction, Face Lift), End-use, Region, and Segment Forecasts, 2023-2030

  • PDF Icon

    Report

  • 172 Pages
  • November 2023
  • Region: Global
  • Grand View Research
  • ID: 4312576
Description Jump to:
The global facial injectable market size is expected to reach USD 24.92 billion by 2030, registering a CAGR of 12.0% from 2023 to 2030, according to the report.,The facial injectables are crucial in anti-aging treatments and are particularly used to stop damage such as hyperpigmentation and early aging. The most popular treatments across all socioeconomic groups are Botox and fillers, which have gained immense popularity.

Growing focus on physical appearance, especially in developing countries is one of the key factors expected to drive the market. In addition, a shift in consumer preference towards minimally invasive procedures is also expected to support market growth. According to the American Society of Plastic Surgeons (ASPS), in 2020, botulinum toxin A and soft tissue fillers were among the top 5 minimally invasive procedures carried out in the U.S. Thus, facial injectable holds high growth prospects in the years to come.

The onset of the pandemic led to nonurgent and cosmetic surgeries being put on hold in the first and second quarters of 2020. Since there were stringent restrictions imposed by the authority bodies as a precaution, the coronavirus outbreak has had an impact on every industry, including the cosmetics industry. Aesthetics-related product supply chains were also impacted. The demand-supply chain across the whole medical device sector has been severely disrupted by the pandemic.

Facial Injectable Market Report Highlights

  • Based on product, the botulinum toxin type A segment is projected to dominate the market throughout the forecast period. It is one of the most popularly used minimally invasive procedures
  • Based on application, the facial line correction segment dominated the market and accounted for the largest revenue share of 33.2% in 2022. This growth is owing to the increasing use of facial injectables for aesthetic procedures such as facial lines, wrinkles on the face, and lip lines
  • Based on end-use, the medSpa segment dominated the market and held the largest revenue share of 46.8% in 2022. All noninvasive treatments are performed in these facilities, which include facial injections, non-invasive body contouring, skin rejuvenation, and laser treatments by experienced professionals
  • North America dominated the market with a revenue share of 39.7% in 2022 owing to the easy availability of the products and the presence of a large number of skilled surgeons
  • The Asia Pacific region is expected to serve as a key revenue-generating center. The region is backed by countries such as India, where a growing focus on physical appearance is expected to create a lucrative opportunity for the market

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Application
1.1.3. End-use
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline.
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. Internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.6. Data for primary interviews in North America
1.3.7. Data for primary interviews in Europe
1.3.8. Data for primary interviews in Asia Pacific
1.3.9. Data for primary interviews in Latin America
1.3.10. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Approach 1: Commodity flow analysis
1.6.2. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Application outlook
2.2.3. End-use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Global Facial Injectable Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Growing aging population
3.2.1.2. Increasing awareness and acceptance of aesthetic treatments
3.2.1.3. Technological advancements
3.2.2. Market Restraint Analysis
3.2.2.1. Regulatory constrains
3.2.2.2. High cost of procedures
3.3. Facial Injectable Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
Chapter 4. Facial Injectable Market: Product Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Collagen & PMMA Microspheres
4.1.2. Hyaluronic Acid (HA)
4.1.3. Botulinum Toxin Type A
4.1.4. Calcium Hydroxylapatite (CaHA)
4.1.5. Poly-L-lactic Acid (PLLA)
4.1.6. Others
4.2. Product Market Share, 2022 & 2030
4.3. Segment Dashboard
4.4. Global Facial Injectable Market by Product Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5.1. Collagen & PMMA Microspheres
4.5.1.1. Collagen & PMMA Microspheres market estimates and forecast 2018 to 2030 (USD Billion)
4.5.2. Hyaluronic Acid (HA)
4.5.2.1. Hyaluronic Acid (HA) market estimates and forecast 2018 to 2030 (USD Billion)
4.5.3. Calcium Hydroxylapatite (CaHA)
4.5.3.1. Calcium Hydroxylapatite (CaHA) market estimates and forecast 2018 to 2030 (USD Billion)
4.5.4. Poly-L-lactic Acid (PLLA)
4.5.4.1. Poly-L-lactic Acid (PLLA) market estimates and forecast 2018 to 2030 (USD Billion)
4.5.5. Others
4.5.5.1. Others market estimates and forecast 2018 to 2030 (USD Billion)
Chapter 5. Facial Injectable Market: Application Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Facial Line Correction
5.1.2. Lip Augmentation
5.1.3. Face Lift
5.1.4. Acne Scar Treatment
5.1.5. Lipoatrophy Treatment
5.1.6. Others
5.2. Application Market Share, 2022 & 2030
5.3. Segment Dashboard
5.4. Global Facial Injectable Market by Application Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5.1. Facial Line Correction
5.5.1.1. Facial Line Correction market estimates and forecast 2018 to 2030 (USD Billion)
5.5.2. Lip Augmentation
5.5.2.1. Lip Augmentation market estimates and forecast 2018 to 2030 (USD Billion)
5.5.3. Face Lift
5.5.3.1. Face Lift market estimates and forecast 2018 to 2030 (USD Billion)
5.5.4. Acne Scar Treatment
5.5.4.1. Acne Scar Treatment market estimates and forecast 2018 to 2030 (USD Billion)
5.5.5. Lipoatrophy Treatment
5.5.5.1. Lipoatrophy Treatment market estimates and forecast 2018 to 2030 (USD Billion)
5.5.6. Others
5.5.6.1. Others market estimates and forecast 2018 to 2030 (USD Billion)
Chapter 6. Facial Injectable Market: End-use Estimates & Trend Analysis
6.1. Definitions and Scope
6.1.1. Medspas
6.1.2. Dermatology Clinics
6.1.3. Hospitals
6.2. End-use Market Share, 2022 & 2030
6.3. Segment Dashboard
6.4. Global Injectable Market by End-use Outlook
6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5.1. Medspas
6.5.1.1. Medspas market estimates and forecast 2018 to 2030 (USD Billion)
6.5.2. Dermatology Clinics
6.5.2.1. Dermatology Clinics market estimates and forecast 2018 to 2030 (USD Billion)
6.5.3. Hospitals
6.5.3.1. Hospitals market estimates and forecast 2018 to 2030 (USD Billion)
Chapter 7. Facial Injectable Market: Regional Estimates & Trend Analysis
7.1. Regional market share analysis, 2022 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Regional Market Share and Leading Players, 2020
7.4.1. North America
7.4.2. Europe
7.4.3. Asia Pacific
7.4.4. Latin America
7.4.5. Middle East and Africa
7.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
7.5.1. North America
7.5.2. Europe
7.5.3. Asia Pacific
7.5.4. Latin America
7.5.5. Middle East and Africa
7.6. Market Size, & Forecasts, Volume and Trend Analysis, 2018 to 2030:
7.7. North America
7.7.1. North America Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.7.2. U.S.
7.7.2.1. U.S. Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.7.2.2. Key Country Dynamics
7.7.2.3. Competitive Scenario
7.7.2.4. Regulatory Framework
7.7.3. Canada
7.7.3.1. Canada Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.7.3.2. Key Country Dynamics
7.7.3.3. Competitive Scenario
7.7.3.4. Regulatory Framework
7.8. Europe
7.8.1. Europe Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.8.2. UK
7.8.2.1. UK Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.8.2.2. Key Country Dynamics
7.8.2.3. Competitive Scenario
7.8.2.4. Regulatory Framework
7.8.3. Germany
7.8.3.1. Germany Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.8.3.2. Key Country Dynamics
7.8.3.3. Competitive Scenario
7.8.3.4. Regulatory Framework
7.8.4. France
7.8.4.1. France Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.8.4.2. Key Country Dynamics
7.8.4.3. Competitive Scenario
7.8.4.4. Regulatory Framework
7.8.5. Italy
7.8.5.1. Italy Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.8.5.2. Key Country Dynamics
7.8.5.3. Competitive Scenario
7.8.5.4. Regulatory Framework
7.8.6. Spain
7.8.6.1. Spain Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.8.6.2. Key Country Dynamics
7.8.6.3. Competitive Scenario
7.8.6.4. Regulatory Framework
7.8.7. Sweden
7.8.7.1. Sweden Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.8.7.2. Key Country Dynamics
7.8.7.3. Competitive Scenario
7.8.7.4. Regulatory Framework
7.8.8. Norway
7.8.8.1. Norway Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.8.8.2. Key Country Dynamics
7.8.8.3. Competitive Scenario
7.8.8.4. Regulatory Framework
7.8.9. Denmark
7.8.9.1. Denmark Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.8.9.2. Key Country Dynamics
7.8.9.3. Competitive Scenario
7.8.9.4. Regulatory Framework
7.9. Asia Pacific
7.9.1. Asia Pacific Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.9.2. China
7.9.2.1. China Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.9.2.2. Key Country Dynamics
7.9.2.3. Competitive Scenario
7.9.2.4. Regulatory Framework
7.9.3. Japan
7.9.3.1. Japan Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.9.3.2. Key Country Dynamics
7.9.3.3. Competitive Scenario
7.9.3.4. Regulatory Framework
7.9.4. India
7.9.4.1. India Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.9.4.2. Key Country Dynamics
7.9.4.3. Competitive Scenario
7.9.4.4. Regulatory Framework
7.9.5. Australia
7.9.5.1. Australia Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.9.5.2. Key Country Dynamics
7.9.5.3. Competitive Scenario
7.9.5.4. Regulatory Framework
7.9.6. Thailand
7.9.6.1. Thailand Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.9.6.2. Key Country Dynamics
7.9.6.3. Competitive Scenario
7.9.6.4. Regulatory Framework
7.9.7. South Korea
7.9.7.1. South Korea Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.9.7.2. Key Country Dynamics
7.9.7.3. Competitive Scenario
7.9.7.4. Regulatory Framework
7.10. Latin America
7.10.1. Latin America Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.10.2. Brazil
7.10.2.1. Brazil Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.10.2.2. Key Country Dynamics
7.10.2.3. Competitive Scenario
7.10.2.4. Regulatory Framework
7.10.3. Mexico
7.10.3.1. Mexico Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.10.3.2. Key Country Dynamics
7.10.3.3. Competitive Scenario
7.10.3.4. Regulatory Framework
7.10.4. Argentina
7.10.4.1. Argentina Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.10.4.2. Key Country Dynamics
7.10.4.3. Competitive Scenario
7.10.4.4. Regulatory Framework
7.11. MEA
7.11.1. MEA Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.11.2. Saudi Arabia
7.11.2.1. Saudi Arabia Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.11.2.2. Key Country Dynamics
7.11.2.3. Competitive Scenario
7.11.2.4. Regulatory Framework
7.11.3. South Africa
7.11.3.1. South Africa Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.11.3.2. Key Country Dynamics
7.11.3.3. Competitive Scenario
7.11.3.4. Regulatory Framework
7.11.4. UAE
7.11.4.1. UAE Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.11.4.2. Key Country Dynamics
7.11.4.3. Competitive Scenario
7.11.4.4. Regulatory Framework
7.11.5. Kuwait
7.11.5.1. Kuwait Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.11.5.2. Key Country Dynamics
7.11.5.3. Competitive Scenario
7.11.5.4. Regulatory Framework
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Manufacturers
8.2. Company Profiles (Manufacturers)
8.2.1. Ispen
8.2.1.1. Company overview
8.2.1.2. Financial performance
8.2.1.3. Product benchmarking
8.2.1.4. Strategic initiatives
8.2.2. Abbvie (Allergen)
8.2.2.1. Company overview
8.2.2.2. Financial performance
8.2.2.3. Product benchmarking
8.2.2.4. Strategic initiatives
8.2.3. Merz Pharma
8.2.3.1. Company overview
8.2.3.2. Financial performance
8.2.3.3. Product benchmarking
8.2.3.4. Strategic initiatives
8.2.4. Galderma
8.2.4.1. Company overview
8.2.4.2. Financial performance
8.2.4.3. Product benchmarking
8.2.4.4. Strategic initiatives
8.2.5. Revance Therapeutics
8.2.5.1. Company overview
8.2.5.2. Financial performance
8.2.5.3. Product benchmarking
8.2.5.4. Strategic initiatives
8.2.6. Sinclair Pharma
8.2.6.1. Company overview
8.2.6.2. Financial performance
8.2.6.3. Product benchmarking
8.2.6.4. Strategic initiatives
List of Tables
Table 1 List of Abbreviations
Table 2 List of Secondary Sources
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Facial Injectable Market: market outlook
Fig. 9 Facial Injectable Market competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook.
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Global Facial Injectable Market driver impact
Fig. 14 Global Facial Injectable Market restraint impact
Fig. 15 Global Facial Injectable Market strategic initiatives analysis
Fig. 16 Global Facial Injectable Market: Product movement analysis
Fig. 17 Global Facial Injectable Market: Product outlook key takeaways
Fig. 18 Collagen & PMMA Microspheres market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 19 Hyaluronic Acid (HA) market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 20 Botulinum Toxin Type A market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 21 Calcium Hydroxylapatite (CaHA) market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 22 Poly-L-lactic Acid (PLLA) market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 23 Others market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 24 Global Facial Injectable Market: Application movement analysis
Fig. 25 Global Facial Injectable Market: Application outlook and key takeaways
Fig. 26 Facial Line Correction market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 27 Lip Augmentation market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 28 Face Lift market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 29 Acne Scar Treatment Augmentation market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 30 Lipoatrophy Treatment market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 31 Others market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 32 Global Facial Injectable Market: End-use movement analysis
Fig. 33 Global Facial Injectable Market: End-use outlook and key takeaways
Fig. 34 Medspas market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 35 Dermatology Clinics market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 36 Hospitals market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 37 Global Facial Injectable Market: regional movement analysis
Fig. 38 Global Facial Injectable Market: regional outlook and key takeaways
Fig. 39 North America Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 40 U.S. Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 41 Canada Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 42 Europe. Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 43 UK Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 44 Germany Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 45 France Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 46 Italy Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 47 Spain Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 48 Sweden Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 49 Norway Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 50 Denmark Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 51 Asia Pacific Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 52 China Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 53 Japan Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 54 India Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 55 Australia Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 56 Thailand Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 57 South Korea Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 58 Latin America Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 59 Brazil Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 60 Mexico Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 61 Argentina Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 62 Middle East and Africa Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 63 Saudi Arabia Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 64 South Africa Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 65 UAE Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 66 Kuwait Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)

Companies Profiled

  • Ispen
  • Abbvie (Allergen)
  • Merz Pharma
  • Galderma
  • Revance Therapeutics
  • Sinclair Pharma

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages172
PublishedNovember 2023
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 10.22 Billion
Forecasted Market Value ( USD ) by 2030 $ 24.92 Billion
Compound Annual Growth Rate12.0%
Regions CoveredGlobal
No. of Companies Mentioned6

Related Topics

Related Reports

Facial Injectables Market by Type, End User - Global Forecast 2025-2030 - Product Image

Facial Injectables Market by Type, End User - Global Forecast 2025-2030

  • Report
  • 198 Pages
  • Global
From
Polynucleotides Injectable Market Size, Share & Trends Analysis Report By Application (Eyes, Lips, Forehead, Jawline & Cheekbones), By End-use (MedSpas, Aesthetic & Cosmetic Centers), By Region, and Segment Forecasts, 2024 - 2030 - Product Image

Polynucleotides Injectable Market Size, Share & Trends Analysis Report By Application (Eyes, Lips, Forehead, Jawline & Cheekbones), By End-use (MedSpas, Aesthetic & Cosmetic Centers), By Region, and Segment Forecasts, 2024 - 2030

  • Report
  • 125 Pages
  • Global
From
Aesthetic Injectable Market Size, Share & Trends Analysis Report by Product (Hyaluronic Acid, Aquatic Light Injections), Application (Facial Line Correction, Lip Augmentation), End-use, Region, and Segment Forecasts, 2024-2030 - Product Image

Aesthetic Injectable Market Size, Share & Trends Analysis Report by Product (Hyaluronic Acid, Aquatic Light Injections), Application (Facial Line Correction, Lip Augmentation), End-use, Region, and Segment Forecasts, 2024-2030

  • Report
  • 143 Pages
  • Global
From
Global Facial Injectable Market Report 2024 - Product Image

Global Facial Injectable Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Aesthetic Injectables Market by Product, Gender, Application, End User - Global Forecast 2025-2030 - Product Image

Aesthetic Injectables Market by Product, Gender, Application, End User - Global Forecast 2025-2030

  • Report
  • 181 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.